US FDA puts clinical hold on Atara’s trials for cancer cell therapies

(Reuters) – Atara Biotherapeutics said on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on the drug developer’s trials for its cancer cell therapies.

(Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar)